Bobes García, Julio
Julio Bobes researcher
Bobes, Julio
VIAF ID: 9045558 (Personal)
Permalink: http://viaf.org/viaf/9045558
Preferred Forms
-
- 100 1 0 ‡a Bobes García, Julio
- 100 1 0 ‡a Bobes, Julio
-
- 100 1 _ ‡a Bobes, Julio
- 100 0 _ ‡a Julio Bobes ‡c researcher
4xx's: Alternate Name Forms (9)
Works
Title | Sources |
---|---|
30 años de alcohol y otras drogas en Asturias | |
Actas de la XI Reunión Nacional de Psiquiatría Biológica | |
Aproximación a la investigación clínica en psiquiatría | |
Autonomía personal y situaciones de dependencia con esquemas y una guía procedimental | |
Banco de instrumentos básicos para la práctica de la psiquiatría clínica | |
Calidad de vida relacionada con la salud discurso de ingreso en la Real Academia de Medicina del Principado de Asturias como académico de número del Ilmo. Prof. Dr. D. Julio Bobes García ... : contestación del Excmo. Prof. Dr. D. Manuel Álvarez-Uría Rico-Villademoros ... : sesión celebrada en Oviedo, el 12 de abril de 2007 | |
Calidad de vida y sueño | |
Casos clínicos en esquizofrenia 2017 : psicopatología en los nuevos tiempos | |
Curso atención primaria Navarra 98 | |
Drogodependencia y crisis conyugales, c1991: | |
Enfermería psiquiátrica | |
Éxtasis aspectos farmacológicos psiquiátricos y médico-legales | |
Éxtasis (MDMA) un abordaje comprehensivo | |
Fobia social | |
Guía para el tratamiento de la adicción a opiáceos con buprenorfina/naloxona | |
Habilidades ejecutivas, evaluadas mediante la escala UPSA, en pacientes con trastorno mental grave (esquizofrenia y trastorno bipolar) | |
La ley del paciente para profesionales sanitarios : (incluye consejos prácticos) | |
Manual de evaluación y tratamiento de drogodependencias | |
Manual de trastornos adictivos | |
Oxcarbazepina uso de oxcarbazepina en adicciones : simposio | |
Pauta en salud mental criterios actuales de comportamiento clínico frente a los trastornos mentales | |
Predictors of posttreatment drinking outcomes in patients with alcohol dependence. | |
Prevalence of Passive Suicidal Ideation in the Early Stage of the Coronavirus Disease 2019 (COVID-19) Pandemic and Lockdown in a Large Spanish Sample | |
Prevention of recurrent suicidal behavior: Case management and psychoeducation | |
The prevention of relapses in first episodes of schizophrenia: The 2EPs Project, background, rationale and study design | |
Psicobiología de la bulimia nerviosa | |
Psiquiatría y psicología en la infancia y adolescencia | |
[Psychometric performance of the 6th version of the Addiction Severity Index in Spanish (ASI-6)]. | |
Psychometric properties of a Spanish-version of the Schizophrenia Objective Functioning Instrument (Sp-SOFI) | |
"Readiness to Change" Predicts Efficacy of Reduction among Smokers with Severe Mental Illness | |
Recomendaciones preventivas y manejo del comportamiento suicida en España | |
[A reduced version of Thinking and Perceptual Style Questionnaire (TPSQ)]. | |
Relevant risk factors of repeated suicidal attempts in a sample of outpatients | |
Remission in schizophrenia: results from a 1-year follow-up observational study. | |
Replication of previous genome-wide association studies of psychiatric diseases in a large schizophrenia case-control sample from Spain. | |
Risk-behaviour screening for identifying adolescents with mental health problems in Europe | |
S240. DETERMINANT FACTORS OF REAL-WORLD FUNCTIONING IN SCHIZOPHRENIA. | |
Safety and effectiveness of olanzapine in monotherapy: a multivariate analysis of a naturalistic study | |
Salud física en los pacientes con transtornos depresivos : estudio naturalístico | |
The "Seroquel" Outcomes Study (SOS): Efficacy and tolerability of quetiapine in a long-term, naturalistic study of patients with schizophrenia | |
Sex-dependent grades of haematopoietic modulation in patients with major depressive episodes are associated with suicide attempts | |
A simulation model to estimate 10-year risk of coronary heart disease events in patients with schizophrenia spectrum disorders treated with second-generation antipsychotic drugs. | |
Smoking cessation programs for persons with schizophrenia: An urgent unmet need. | |
Sociodemographic factors associated with personality traits assessed through the TCI | |
Spanish consensus on the physical health of patients with depressive disorders | |
Spanish validation of the Barcelona TEMPS-A questionnaire in patients with bipolar disorder and general population | |
Spanish validation of the Negative Symptom Assessment-16 | |
The state of psychiatry in Spain | |
The Suicide Prevention and Intervention Study (SURVIVE): study protocol for a Spanish multisite cohort study with nested randomized-controlled trials | |
Suicide prevention for youth--a mental health awareness program: lessons learned from the Saving and Empowering Young Lives in Europe (SEYLE) intervention study | |
Suicide prevention in Spain: an uncovered clinical need. | |
Suicide prevention strategies revisited: 10-year systematic review | |
Suicide. The post-COVID era: A time for action | |
Teacher satisfaction with school and psychological well-being affects their readiness to help children with mental health problems | |
Topiramate for the treatment of alcohol dependence: comparison with naltrexone. | |
Trastorno de ansiedad generalizada | |
Trastorno de estrés postraumático en esquemas | |
Los trastornos del sueño | |
Trastornos mentales en atención primaria | |
Treated Incidence of Psychotic Disorders in the Multinational EU-GEI Study. | |
Treatment adherence and quality of sleep in schizophrenia outpatients | |
Validación de las versiones en español de la Clinical Anxiety Scale y del Physician Questionnaire para la evaluación de los trastornos de ansiedad | |
Validation of a Spanish version of the Columbia-Suicide Severity Rating Scale (C-SSRS). | |
Validation of the Spanish Personal and Social Performance scale (PSP) in outpatients with stable and unstable schizophrenia. | |
Walking capacity is associated with health related quality of life and physical activity level in patients with schizophrenia: a preliminary report. | |
White Noise Speech Illusions: A Trait-Dependent Risk Marker for Psychotic Disorder? | |
Why prudence is needed when interpreting articles reporting clinical trial results in mental health | |
Will changes in alcohol and tobacco use be seen during the COVID-19 lockdown? |